The groundbreaking therapy of the medication represents a exciting advance in the handling of type 2 diabetes. Unlike existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide059857.diowebhost.com/97236034/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment